Vitrolife AB (publ) (STO:VITR)

Vitrolife AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	860	809	1,135	861	578	630
Cash & Short-Term Investments	860	809	1,135	861	578	630
Cash Growth	-22.45%	-28.72%	31.82%	48.96%	-8.25%	-35.29%
Accounts Receivable	772	665	648	503	454	391
Other Receivables	95	131	86	79	88	39
Receivables	867	796	734	582	542	430
Inventory	447	413	422	413	405	313
Prepaid Expenses	83	74	66	57	47	32
Other Current Assets	-	-	-	1	-	2
Total Current Assets	2,257	2,092	2,357	1,914	1,572	1,407
Property, Plant & Equipment	552	515	428	349	318	333
Goodwill	4,537	4,443	10,121	9,591	13,874	12,995
Other Intangible Assets	3,833	3,663	4,209	4,253	4,603	4,494
Long-Term Deferred Tax Assets	153	153	144	111	102	92
Long-Term Deferred Charges	-	172	133	61	45	59
Other Long-Term Assets	89	86	54	50	37	49
Total Assets	11,421	11,124	17,446	16,329	20,551	19,429

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	185	208	203	171	181	173
Accrued Expenses	229	148	151	113	134	186
Current Portion of Long-Term Debt	-	-	115	114	153	429
Current Portion of Leases	47	43	45	33	29	27
Current Income Taxes Payable	49	15	26	19	27	25
Current Unearned Revenue	-	70	65	52	46	35
Other Current Liabilities	103	131	100	55	51	79
Total Current Liabilities	613	615	705	557	621	954
Long-Term Debt	1,603	1,490	1,837	1,875	1,988	1,944
Long-Term Leases	75	72	92	67	55	82
Pension & Post-Retirement Benefits	-	54	49	44	31	27
Long-Term Deferred Tax Liabilities	943	955	1,056	1,035	1,102	1,069
Other Long-Term Liabilities	69	43	66	28	14	12
Total Liabilities	3,303	3,229	3,805	3,606	3,811	4,088

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8,118	28	28	28	28	28
Additional Paid-In Capital	-	13,544	13,544	13,544	13,544	13,544
Retained Earnings	-	-6,755	-1,608	-1,993	2,000	1,730
Comprehensive Income & Other	-	1,077	1,675	1,143	1,164	20
Total Common Equity	8,118	7,894	13,639	12,722	16,736	15,322
Minority Interest	-	1	2	1	4	19
Shareholders' Equity	8,118	7,895	13,641	12,723	16,740	15,341
Total Liabilities & Equity	11,421	11,124	17,446	16,329	20,551	19,429

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,725	1,605	2,089	2,089	2,225	2,482
Net Cash (Debt)	-865	-796	-954	-1,228	-1,647	-1,852
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.40	-5.88	-7.04	-9.07	-12.16	-16.16
Filing Date Shares Outstanding	132.73	135.42	135.42	135.39	135.39	135.39
Total Common Shares Outstanding	132.73	135.42	135.42	135.39	135.39	135.39
Working Capital	1,644	1,477	1,652	1,357	951	453
Book Value Per Share	61.16	58.29	100.71	93.96	123.61	113.17
Tangible Book Value	-252	-212	-691	-1,122	-1,741	-2,167
Tangible Book Value Per Share	-1.90	-1.57	-5.10	-8.29	-12.86	-16.01
Buildings	-	115	129	124	-	92
Machinery	-	613	568	497	-	397
Construction In Progress	-	98	26	6	-	15

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error